The Next Generation Peptide for Neural & Inflammatory Health

Introduction

ARA-290 is a groundbreaking peptide derived from erythropoietin (EPO). Unlike traditional EPO, ARA-290 carries no risk of increasing red blood cell mass. Instead, it activates a specific innate repair receptor (IRR) that promotes tissue protection, nerve healing, and inflammation control.

Researchers and biohackers are increasingly turning to ARA-290 for its potential in neuropathy, sarcoidosis, and systemic inflammatory conditions.

How it Works

ARA-290 binds exclusively to the CD131 receptor, also known as the innate repair receptor. This binding triggers a cascade of anti-inflammatory and tissue-repair signals.

Key mechanisms include:

• Reducing pro-inflammatory cytokines (TNF-α, IL-6)
• Increasing regulatory T-cells (Tregs)
• Promoting neuronal survival and axonal regeneration
• Protecting pancreatic beta-cells from damage

Proven Benefits

1. Small Fiber Neuropathy Relief

Clinical studies show ARA-290 significantly reduces pain, improves nerve density, and enhances quality of life in patients with small fiber neuropathy (SFN).

2. Cardiac Protection

The peptide reduces ischemia-reperfusion injury following heart attack or surgery, preserving heart muscle function.

3. Kidney & Metabolic Support

ARA-290 improves renal function and reduces albuminuria in diabetic kidney disease models. It also enhances insulin sensitivity.

4. Sarcoidosis Management

Patients with pulmonary sarcoidosis report less fatigue, better walking distance, and lower inflammatory markers after ARA-290 therapy.

5. Wound Healing

By modulating inflammation locally, ARA-290 accelerates healing of chronic ulcers and surgical wounds.

Other Peptides

Peptide	Primary Use	Risk of RBC Increase	Best For
ARA-290	Nerve repair, inflammation	None	Neuropathy, sarcoidosis
BPC-157	Gut, tendon, muscle healing	None	Soft tissue injuries
TB-500	Angiogenesis, recovery	None	Muscle tears, heart repair
EPO	Anemia, endurance	High (RBC boost)	Oxygen delivery

Dosage & Protocol Guidelines

For research purposes only. Typical protocols:

• Standard dose: 4 mg subcutaneous injection
• Frequency: Once daily for 10–28 days
• Cycle length: 2–4 weeks followed by washout
• Reconstitution: Use bacteriostatic water. Gently swirl – do not shake.

Note: Always consult published studies for current dosing protocols. Not for human use without prescription.

Side Effects & Safety

ARA-290 is remarkably well-tolerated. Reported effects are mild and rare:

• Minor injection site redness
• Temporary mild fatigue
• No hypertension or thrombosis risk (unlike EPO)

Long-term safety data remains limited to animal and early human trials.

Where to Find High-Quality

When sourcing ARA-290 for research, prioritize suppliers offering:

• 🔬 Third-party HPLC purity testing (>98% recommended)
• ❄️ Lyophilized powder shipped with ice packs
• 📄 Certificate of Analysis (COA) per batch
• 🔒 Discreet, temperature-controlled shipping

Frequently Asked Questions

Is ARA-290 legal?
ARA-290 is sold for research purposes only. Legality varies by country. Always check local regulations before purchasing.

How does ARA-290 feel?
Users report gradual reduction in nerve pain, improved energy, and better sleep starting around day 5–7 of daily dosing.

Can I stack ARA-290 with other peptides?
Yes. Common stacks include BPC-157 for broader healing or TB-500 for systemic recovery. Always stagger administration times.

The Bottom Line

By targeting the innate repair receptor without EPO’s side effects, it offers new hope for neuropathy, cardiac injury, kidney disease, and chronic inflammation. For researchers, it’s an essential tool in the immunology and regenerative medicine toolkit.

Ready to explore ARA-290 for your next research study? Choose a verified supplier with published COAs and sterile handling protocols.

---